ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
prov:wasAttributedTo |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
prov:wasAttributedTo |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEA0E351EBF25A8D2C5 |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA0E351EBF25A8D2C5 |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
ripe:resultOutcome |
yes |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
tido:answers |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.01.3. Do other studies by the research team highlight causes for concern? |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |
tido:answers |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.0research-team-related concerns |
ripekg:retraction-notice/62423Green and rapid and instrumental one-pot method for the synthesis of imidazolines having potential anti-SARS-CoV-2 main protease activity |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA0E351EBF25A8D2C5-inspectai-1-3 |